pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 3
nucresiran
nucresiran [INN]
Familial Amyloid Cardiomyopathy
$ALNY
ALNYLAM PHARMACEUTICALS, INC.
Phase 2
nulabeglogene autogedtemcel
nulabeglogene autogedtemcel
Sickle Cell Disease
Kamau Therapeutics Inc
Marketed
nusinersen
Spinraza (nusinersen)
Spinal Muscular Atrophy (SMA)
$BIIB
BIOGEN INC.
← prev
page 237 of 271
next →
Pain
89
Neurology
1
Phase 2
nuvisertib hydrochloride
nuvisertib hydrochloride
Secondary Myelofibrosis
Sumitomo Pharma America Inc
Phase 2
nuzefatide pevedotin
nuzefatide pevedotin [INN]
Gastric Cancer
$BCYC
BICYCLE THERAPEUTICS PLC
Marketed
nystatin
Nystatin (nystatin [INN])
Chronic Mucocutaneous Candidiasis
Actavis Mid Atlantic LLC
Phase 3
obecabtagene autoleucel
Aucatzyl (obecabtagene autoleucel)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
$AUTL
Autolus Therapeutics plc
Phase 3
obefazimod
obefazimod
Ulcerative Colitis
Abivax SA
Phase 1
oberotatug ravtansine
oberotatug ravtansine
Adenoid Cystic Carcinoma (ACC)
Oxford BioTherapeutics Ltd
Phase 3
obexelimab
obexelimab
Immunoglobulin G4-Related Disease (IgG4-RD)
$ZBIO
Zenas BioPharma, Inc.
Phase 3
obicetrapib calcium
obicetrapib calcium
Heterozygous Familial Hypercholesterolemia (heFH)
NewAmsterdam Pharma Company NV
Marketed
obiltoxaximab
Anthim (obiltoxaximab)
Anthrax
Elusys Therapeutics Inc
Phase 2
obrixtamig
obrixtamig [INN]
Small-Cell Lung Cancer
Boehringer Ingelheim International GmbH
Phase 3
obudanersen sodium
obudanersen sodium
Angelman Syndrome
$IONS
IONIS PHARMACEUTICALS INC
Phase 2
ocifisertib
ocifisertib [INN]
Refractory Acute Myeloid Leukemia
Treadwell Therapeutics Inc
Marketed
ocrelizumab
Ocrevus (ocrelizumab)
Primary Progressive Multiple Sclerosis (PPMS)
Genentech Inc
Phase 3
ocrelizumab biosimilar
Relapsing Remitting Multiple Sclerosis (RRMS)
Celltrion Inc
pre_registration
octreotide LA
Oclaiz (octreotide)
Acromegaly
Camurus AB
Preclinical
octreotide acetate
Octreotide Acetate
Intracranial Hypertension
NBO Pharma LLC
Marketed
octreotide acetate DR
Mycapssa (octreotide acetate)
Acromegaly
Chiasma Inc
Marketed
octreotide acetate LA
Sandostatin LAR (octreotide acetate)
Diarrhea
$NVS
NOVARTIS AG
Phase 2
odafosfamide
odafosfamide [INN]
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphobla…
OBI Pharma Inc
Phase 2
odatroltide
odatroltide [INN]
Acute Ischemic Stroke
Lumosa Therapeutics Co Ltd
Phase 3
odronextamab
odronextamab
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associat…
$REGN
REGENERON PHARMACEUTICALS, INC.
Phase 2
olafertinib
olafertinib [INN]
Non-Small Cell Lung Cancer
Checkpoint Therapeutics Inc
pre_registration
olanzapine ER
olanzapine
Schizophrenia
$TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Marketed
olanzapine pamoate XR
Zyprexa Relprevv (olanzapine pamoate)
Schizophrenia
CHEPLAPHARM Arzneimittel GmbH
Phase 2
olaptesed pegol
olaptesed pegol [INN]
Glioblastoma Multiforme (GBM)
TME Pharma AG
Phase 2
olastrocel
olastrocel [INN]
Type 1 Diabetes (Juvenile Diabetes)
$CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Phase 2
olatorepatide
olatorepatide [INN]
Obesity
$REGN
REGENERON PHARMACEUTICALS, INC.
